Considering that cancer treatment requires the simultaneous modulation of different pathways and biological functions playing pivotal roles in maintaining cell homeostasis, redox balance, and regulating cell death, xCT targeting, together with the reactivation of p53, can be the right track to pursue. The gene discussed is TP53; the disease is cancer.